Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Baroness Finlay of Llandaff, and are more likely to reflect personal policy preferences.
The provisions of the Bill were ultimately enacted through the Online Safety Act 2023.
A Bill to require OFCOM to establish a unit to advise the Secretary of State regarding the use of social media platforms to encourage or assist serious self-harm and activities associated with risk of suicide; and for connected purposes
A Bill to make provision for equitable access to palliative care services; for advancing education, training and research in palliative care; and for connected purposes
A bill to make provision for NHS service commissioners to ensure that persons for whom they have responsibility for commissioning physical and mental health services have access to specialist and generalist palliative care and support services; to enable hospices to access pharmaceutical services on the same basis as other services commissioned by a clinical commissioning group; and to make provision for treatment of children with a life-limiting illness
A Bill to make provision for equitable access to palliative care services; for advancing education, training and research in palliative care; and for connected purposes.
Baroness Finlay of Llandaff has not co-sponsored any Bills in the current parliamentary sitting
DfT is committed to long term strategies for road investment. As announced in the October Budget, a decision was taken to postpone the start of the third Road Investment Strategy (RIS3), to allow Ministers time to make an assessment of priorities for roads. DfT will provide funding through an Interim Settlement to National Highways covering 2025-26, to allow for important maintenance and enhancement activities to continue. The planned start of RIS3 is April 2026 and the drink-drive limit will not form part of the RIS.
This Government takes road safety seriously, and we are committed to reducing the numbers of those killed and injured on our roads. Since the general election, the Department has begun work on a new Road Safety Strategy, the first in over a decade. The Department will share more details in due course.
The Government is committed to better care and support for people living with myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). We have reconvened the ME/CFS Task and Finish Group, including senior Department and cross-Government officials, ME/CFS specialists and researchers, representatives from NHS England, the National Institute for Health and Care Excellence, the National Institute for Health and Care Research (NIHR), the Medical Research Council (MRC), the devolved administrations, ME/CFS charities, and organisations and patients with lived experience of ME/CFS.
We cannot comment on the exact content of the final delivery plan at this time, but it will be shaped by responses to the 2023 consultation on the interim delivery plan, alongside continued stakeholder engagement via the ME/CFS Task and Finish Group, with three broad themes of boosting research, improving attitudes and education, and bettering the lives of those living with ME/CFS. We aim to publish the final delivery plan by the end of March 2025.
Research is an important pillar of the delivery plan for ME/CFS. Future planned action to support research in this area will take a cross-sectoral and inclusive approach, recognising the value of patient and public representatives in particular.
The Department funds research on ME/CFS through the NIHR and the MRC. The NIHR and the MRC remain committed to funding high-quality research to understand the causes, consequences, and treatment of ME/CFS, and are actively exploring the next steps for stimulating further research in this area. The MRC and NIHR currently fund research through a variety of routes, including infrastructure, research programmes, capacity building, through for example research fellowships, and, in the case of the NIHR, research delivery to support recruitment to studies. The NIHR welcomes the opportunity to work collaboratively with partners, including patient representative groups and industry, to stimulate further research in this area.
The Government is committed to better care and support for people living with myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). We have reconvened the ME/CFS Task and Finish Group, including senior Department and cross-Government officials, ME/CFS specialists and researchers, representatives from NHS England, the National Institute for Health and Care Excellence, the National Institute for Health and Care Research (NIHR), the Medical Research Council (MRC), the devolved administrations, ME/CFS charities, and organisations and patients with lived experience of ME/CFS.
We cannot comment on the exact content of the final delivery plan at this time, but it will be shaped by responses to the 2023 consultation on the interim delivery plan, alongside continued stakeholder engagement via the ME/CFS Task and Finish Group, with three broad themes of boosting research, improving attitudes and education, and bettering the lives of those living with ME/CFS. We aim to publish the final delivery plan by the end of March 2025.
Research is an important pillar of the delivery plan for ME/CFS. Future planned action to support research in this area will take a cross-sectoral and inclusive approach, recognising the value of patient and public representatives in particular.
The Department funds research on ME/CFS through the NIHR and the MRC. The NIHR and the MRC remain committed to funding high-quality research to understand the causes, consequences, and treatment of ME/CFS, and are actively exploring the next steps for stimulating further research in this area. The MRC and NIHR currently fund research through a variety of routes, including infrastructure, research programmes, capacity building, through for example research fellowships, and, in the case of the NIHR, research delivery to support recruitment to studies. The NIHR welcomes the opportunity to work collaboratively with partners, including patient representative groups and industry, to stimulate further research in this area.
It is unacceptable that alcohol deaths are now at record high levels. Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. The Department will continue to work across Government to better understand how we can best reduce alcohol-related harms.
Both NHS England and integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the National Institute for Health and Care Excellence (NICE).
Where treatments are approved by NICE through the Technology Appraisals programme, the National Health Service is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.
During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. Service Development Funding (SDF) is available to support Cancer Alliances to deliver the priorities set out in the 2024/25 NHS Operational Planning Guidance; £266 million in SDF is being provided to Cancer Alliances in 2024/25. Funding comprises two allocations: place-based, provided to all Alliances on a fair shares basis; and, targeted, provided to a selection of Alliances for agreed targeted projects. Cancer SDF is provided to Cancer Alliances via their lead ICBs to enable them to deliver on NHS-wide priorities for cancer, in line with their local delivery plans which are included in their funding agreement.
The adoption of new treatments, including increasing the number and availability of minimally invasive cancer treatments, into the National Health Service in England is generally the result of National Institute for Health and Care Excellence (NICE) guidance and commissioner decisions. Both NHS England and the integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the NICE.
Where treatments are approved by the NICE through the Technology Appraisals programme, the NHS is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.
During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation.
We are committed to training the staff we need to get patients seen on time. The Government will make sure the NHS has the staff it needs to be there for all of us when we need it, including cancer patients.
At present there is no mandatory time period within which all funeral directors across England and Wales should collect the body of a person who has died and take them into their care.
The introduction of regulation into the funeral director sector requires thorough consideration due to the complexity and sensitive nature of the area. It is essential to ensure that the rights and dignity of deceased individuals and their bereaved family members are protected, while implementing measures that are proportionate.
For that reason, the Government is considering the full range of possible next steps to ensure appropriate standards are in place, including the potential for introducing some form of appropriate, proportionate regulation of funeral directors. An update on next steps will be provided in due course.
The Law Commission is currently undertaking its “Burial, Cremation and New Funerary Methods” project which seeks to create a future-proof legal framework to address what happens to our bodies after we die and to make recommendations that will provide modern, certain and consistent regulation across different funerary methods. As part of this project, the Law Commission has considered issues surrounding direct cremation. Its recent “Burial and Cremation” consultation document invited evidence from consultees as to whether, in relation to direct cremations, there are cases where an applicant for the cremation will not know which crematorium will be used at the time of application.
The Government does not currently have plans to require all funeral directors and crematoria to publish their schedule of planned direct cremations. Direct cremations are subject to the same legislation as any other cremation. The Government will consider any changes to the legal framework governing direct cremations as part of any wider recommendations made by the Law Commission in due course. As the Law Commission project is still ongoing, we do not want to pre-empt its recommendations. We look forward to carefully considering these once published, which we expect to be towards the end of 2025.